Council for europe portal
Language : en Search
Choose language

Programme Results CD-P-PH/PHO

Committee of Experts on the Classification of Medicines as regards their Supply (CD-P-PH/PHO)

Programme Results 2008-2010

  • Revisions of the appendices of Resolution ResAP(2007)1 on the classification of medicines as regards their supply (2008 & 2009); 2010 revision in progress.
  • Maintenance and regular updates of the database "Melclass" published on the EDQM website: the database contains recommendations for classification (in accordance with the Resolution ResAP(2007)1) (supply status, supply conditions such as maximal daily dose, maximal strength per unit, maximal quantity per pack, indications, additional information) for about 2440 active pharmaceutical ingredients for a given specific therapeutic use (ATC class) and classification information on a national level for more than 10 000 active pharmaceutical ingredients for a given specific therapeutic use (ATC class).
  • Evidence-based classification reviews: ACETYLSALICYLIC ACID, LOPERAMIDE, A07DA03, CODEINE, R05DA04, ANTIHISTAMINES FOR SYSTEMIC USE (R06A): DIPHENHYDRAMINE, R06A A02, CLEMASTINE, R06A A04, CHLORPHENOXAMINE, R06AA06, DIPHENPYRALINE, R06A A07, CARBINOXAMINE, R06A A08, DOXYLAMINE, R06A A09, DIMETINDENE, R06A B03, CHLORPHENAMINE, R06A B04, PHENIRAMINE, R06AB05, DEXBROMPHENIRAMINE, R06AB06, MEPYRAMINE, R06AC01, TRIPELENAMINE, R06AC04, METAPYRILENE, R06AC05, THONZYLAMINE, R06AC06, ALIMEMAZINE, R06A D01, PROMETHAZINE, R06A D02, THIETHYLPERAZINE, R06A D03, MEQUITAZINE, R06A D07, OXOMEMAZINE, R06A D08, BUCLIZINE, R06A E01, CYCLIZINE, R06A E03, MECLOZINE, R06A E05, OXATOMIDE, R06A E06, CETIRIZINE, R06A E07, LEVOCETIRIZINE, R06A E09, CYPROHEPTADINE, R06A X02, TRIPROLIDINE, R06A X07, AZATADINE, R06A X09, ASTEMIZOLE, R06A X11, TERFENADINE, R06A X12, LORATADINE, R06A X13, KETOTIFEN, R06A X17, ACRIVASTINE, R06A X18, AZELASTINE, R06A X19, EBASTIN, R06A X22, MIZOLASTINE, R06A X25, FEXOFENADINE, R06A X26, DESLORATADINE, R06AX27, RUPATADINE, R06A X28, Azelaic acid, D10A X03, OMEPRAZOL, A02B C01; EMEDASTINE, S01GX06, AZELASTINE, S01GX07, KETOTIFEN, S01GX08, OLOPATADINE, S01GX09, EPINASTINE, S01GX010; PROMETHAZINE, D04AA10, DIMETINDENE D04AA13, DIPHENHYDRAMINE, D04AA32, CHLORPHENOXAMINE, D04AA34; CROMOGLICIC ACID, R01AC 01, LEVOCABASTINE, R01AC 02, AZELASTINE, R01AC 03, SPAGLUMIC ACID, R01AC 04
  • Ongoing survey: implications of electronic prescribing and new modes of medicines' supply such as e-pharmacies, via non-pharmacy-outlets on the classification practices into prescription and non-prescription medicines.

 

twitter facebook googleplus pinterest linkedin email